USPTO trademark

DBITE

Under examinationUSPTOWord markClass 5Class 9Class 42

"DBITE" is a word mark owned by Amgen Inc., filed at the USPTO on June 15, 2026. It is under examination and covers classes 5, 9 and 42.

View Amgen Inc. portfolioGet this data via the API
Official USPTO record
DBITE trademark as filed
As filed with the USPTO
Status
Under examination
Since October 27, 2026
Filed
June 15, 2026
Registered
Not yet
Expires
Not recorded
Application no.
99885409
Registration no.
Not yet
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
3 classes
Ownership

Who owns DBITE

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Amgen Inc.

AMGN · Thousand Oaks, United States

2,426 trademarks in the portfolioView company

Representative

Elizabeth K. Rucki

Amgen Inc.

Goods and services

What the mark covers

The products and services DBITE is filed for, grouped by Nice class.

  • Medicaments, namely, polypeptides, for use in the treatment of tumorous diseases, cancer, allergies, autoimmunity, inflammation, osteoporosis, graft versus host diseases, transplant rejection, cardiovascular diseases, metabolic diseases, neurological diseases, and minimal residual diseases

  • Downloadable educational materials, namely, video recordings, books, and printable booklets on therapeutic polypeptides and use thereof

  • Providing medical and scientific research information regarding therapeutic polypeptides and use thereof; providing a website featuring medical and scientific research information regarding antibody derivatives and use thereof; providing scientific information regarding antibody derivatives and use thereof

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Assigned to examiner
  2. New application office supplied data entered
  3. Application filing receipt mailed
  4. New application entered
FAQ

About DBITE

Who owns the trademark "DBITE"?

The USPTO trademark "DBITE" (application 99885409) is owned by Amgen Inc.

What is the status of "DBITE"?

Its status at the USPTO is: under examination.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull DBITE and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019ed402-9f25-77f0-9e12-c74f1dd8fc1b
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019ed402-9f25-77f0-9e12-c74f1dd8fc1b",
  "object": "trademark",
  "mark_text": "DBITE",
  "status": {
    "primary": "pending",
    "stage": "examining"
  },
  "office_code": "US",
  "application_number": "99885409",
  "filing_date": "2026-06-15",
  "nice_classes": [
    5,
    9,
    42
  ],
  "owners": [
    {
      "name": "Amgen Inc.",
      "entity_id": "ent_019eb6fb-7ab7-71bf-a46d-b0ba9848c4af"
    }
  ]
}